Alexander N Bennett1,2, Helena Marzo-Ortega3,4, Daljit Kaur-Papadakis3,4, Amer Rehman. 1. From the Academic Department of Military Rehabilitation, Defence Medical Rehabilitation Centre (DMRC), Headley Court, Epsom; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; AbbVie Ltd., Maidenhead; Department of Radiology, Countess of Chester Hospital, Chester, UK. alexander.n.bennett@btinternet.com. 2. A.N. Bennett, PhD, FRCP, Consultant Rheumatologist, Academic Department of Military Rehabilitation, DMRC, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; H. Marzo-Ortega, LMS, MRCP, PhD, Consultant Rheumatologist, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; D. Kaur-Papadakis, PhD, Senior Medical Science Liaison, Rheumatology, AbbVie Ltd.; A. Rehman, MRCP, FRCR, Consultant Radiologist and Divisional Medical Director, Diagnostics and Pharmacy, Department of Radiology, Countess of Chester Hospital. alexander.n.bennett@btinternet.com. 3. From the Academic Department of Military Rehabilitation, Defence Medical Rehabilitation Centre (DMRC), Headley Court, Epsom; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; AbbVie Ltd., Maidenhead; Department of Radiology, Countess of Chester Hospital, Chester, UK. 4. A.N. Bennett, PhD, FRCP, Consultant Rheumatologist, Academic Department of Military Rehabilitation, DMRC, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; H. Marzo-Ortega, LMS, MRCP, PhD, Consultant Rheumatologist, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; D. Kaur-Papadakis, PhD, Senior Medical Science Liaison, Rheumatology, AbbVie Ltd.; A. Rehman, MRCP, FRCR, Consultant Radiologist and Divisional Medical Director, Diagnostics and Pharmacy, Department of Radiology, Countess of Chester Hospital.
Abstract
OBJECTIVE: Magnetic resonance imaging (MRI) is involved in the assessment of axial spondyloarthritis (axSpA); however, anecdotal evidence suggests diverse practice among radiologists. The objective of this study was to describe current practice in the use of MRI for assessment of axSpA by UK radiologists. METHODS: Six hundred ninety-nine UK radiologists were invited to complete an online survey. Availability of MR scanners, familiarity with axSpA disease-specific lesions, and MRI protocols and definitions of positive sacroiliac joint (SIJ) or spinal MRI were assessed. RESULTS: Two-hundred sixty-nine radiologists (38%) from 131/180 (73%) acute UK National Health Service trusts/health boards responded. MRI waiting times < 2 months were reported by 90% of radiologists. Twenty-nine radiologists (11%) used contrast as standard, 256 (91%) used T1 and short-tau inversion recovery, and 172 (64%) also used T2 sequences. Five percent scanned only SIJ, 33% scanned SIJ and lumbar spine, 29% scanned SIJ and thoracolumbar spine, and 30% scanned SIJ and the whole spine. Mean scan time was 34 min. Eighteen percent did not use the subchondral bone marrow edema of the SIJ to help diagnose axSpA and 18% did not use the inflammatory vertebral corner lesions to assist diagnosis. Awareness of axSpA was reported by 75% of radiologists, and awareness of definitions for positive MRI of SIJ and spine by 31% and 25%, respectively. CONCLUSION: These data highlight the need for better rheumatology-radiology collaboration on the identification of diagnostic axSpA MRI lesions and support the need for a consensus on the most appropriate MRI protocols for the assessment of axSpA.
OBJECTIVE: Magnetic resonance imaging (MRI) is involved in the assessment of axial spondyloarthritis (axSpA); however, anecdotal evidence suggests diverse practice among radiologists. The objective of this study was to describe current practice in the use of MRI for assessment of axSpA by UK radiologists. METHODS: Six hundred ninety-nine UK radiologists were invited to complete an online survey. Availability of MR scanners, familiarity with axSpA disease-specific lesions, and MRI protocols and definitions of positive sacroiliac joint (SIJ) or spinal MRI were assessed. RESULTS: Two-hundred sixty-nine radiologists (38%) from 131/180 (73%) acute UK National Health Service trusts/health boards responded. MRI waiting times < 2 months were reported by 90% of radiologists. Twenty-nine radiologists (11%) used contrast as standard, 256 (91%) used T1 and short-tau inversion recovery, and 172 (64%) also used T2 sequences. Five percent scanned only SIJ, 33% scanned SIJ and lumbar spine, 29% scanned SIJ and thoracolumbar spine, and 30% scanned SIJ and the whole spine. Mean scan time was 34 min. Eighteen percent did not use the subchondral bone marrow edema of the SIJ to help diagnose axSpA and 18% did not use the inflammatory vertebral corner lesions to assist diagnosis. Awareness of axSpA was reported by 75% of radiologists, and awareness of definitions for positive MRI of SIJ and spine by 31% and 25%, respectively. CONCLUSION: These data highlight the need for better rheumatology-radiology collaboration on the identification of diagnostic axSpA MRI lesions and support the need for a consensus on the most appropriate MRI protocols for the assessment of axSpA.
Authors: Alexis Jones; Timothy J P Bray; Peter Mandl; Margaret A Hall-Craggs; Helena Marzo-Ortega; Pedro M Machado Journal: Rheumatology (Oxford) Date: 2019-11-01 Impact factor: 7.580
Authors: Raquel Almodóvar; Ángel Bueno; Enrique Batlle; Emma Beltrán-Catalán; Daniel Bernabeu; Carmen Castro Copete; Angela Cepero; Concha Crespo; Fernando Díez; Cristina Fernández-Carballido; Fran García Lorente; Angel Gil De Miguel; Xavier Juanola; Luis Linares; Rafael Montero Pérez-Barquero; Carmen Castro; Manuel José Moreno Ramos; Mireia Moreno; Victoria Navarro-Compán; Christopher Pack; Carlos Quiles; Maite Veintemillas; Pedro Zarco Journal: Rheumatol Int Date: 2019-09-18 Impact factor: 2.631